BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
 
A Major New Proteomics Software offering the World’s Fastest 2D Gel Analysis

November 12th 2004 Cambridge, UK: From the developers of Syngene, a world-leading manufacturer of image analysis solutions, comes Dymension, a revolutionary new software enabling scientists to increase productivity in their proteomics research, by accurately analysing 2D gels in seconds.

Marketed under the Dymension brand, this revolutionary software can analyse a typical 2D gel image in seconds compared to many minutes or hours which is typical for all other 2D analysis software currently on the market. In addition to its outstanding speed, Dymension has a new spot finding algorithm for superb spot detection, resulting in minimal post editing. Coupled with a completely automatic gel alignment process, Dymension eliminates the need for “walk away time” whilst waiting for the image to be analysed. Instead, the whole imaging process right through to results and report generation takes just a few minutes.

Dymension has been extensively tested and verified by a number of independent scientists in eminent academic institutes across the world. They have confirmed the speed, accuracy and ease of use of Dymension against other leading 2D analysis software packages.

Dymension has taken over 5 years to develop and represents a substantial investment from the Company. Its high levels of automation and integration provide complete quality assurance from data to printed report. The confidence in Dymension’s capabilities is reflected in the novel methods of purchasing it, as the software can be bought outright, rented or paid for on a per use basis.

Paul Ellwood, Sales & Marketing Director explained: “We have been developing software for life science applications for more than 17 years, so have a long and distinguished history of producing excellent software to meet scientists’ ever changing requirements. The technically challenging evolution of Dymension has been driven by global demand for faster 2D analysis and we are convinced that our resulting Dymension software is now a world-class solution to this important proteomics problem.”


-Ends-


For Further Information Contact:
Jayne Arthur, Syngene, Beacon House, Nuffield Road, Cambridge, CB4 1TF, UK.
Tel: +44(0) 1223-727123 Fax +44 (0) 1223-727101
Email: jayne.arthur@syngene.com Web site: www.syngene.com

Editor Contact:
Dr Sue Pearson, PO Box 170, Hitchin, Hertfordshire SG5 3GD, UK.
Tel/Fax +44(0) 1462- 635327 Email: sue6.pearson@ntlworld.com


Note to Editors

About Syngene


Syngene is a world-leading supplier of integrated imaging solutions for analysis and documentation of gel-based information. Syngene’s systems are used by more than 10,000 research organisations and over 50,000 individual scientists world-wide and include many of the world’s top pharmaceutical companies and major research institutes.

Syngene, founded in 1997 is a division of the Synoptics Group based in Cambridge, UK. The Group’s other divisions, Syncroscopy and Synbiosis, specialise in digital imaging solutions for microscopy and microbial applications respectively. Synoptics currently employs 50 people in its UK and subsidiary operation in Frederick, USA. The Group has profitable revenue of almost $10 million and continues to grow rapidly.
 

 
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.